COVID-19 vaccine found to be 94.5% effective, says US biotech firm Moderna
Share Via Email
Published: 17th November 2020 04:59 PM |
Last Updated: 17th November 2020 05:00 PM
The race to develop a #Covid19 vaccine picked up pace on Monday with US biotech firm Moderna announcing its candidate was 94.5% effective in interim analysis of its phase 3 trials, which involved more than 30,000 volunteers.